INEXIA
Inexia aims to develop intranasally administered orexin positive modulators for the treatment of neurological diseases.The orexin system is a key regulator of behavioural arousal, wakefulness and sleep. The loss of the orexin neurons has been shown to be strongly linked to multiple neurological conditions including narcolepsy. In this indication, orexin receptors remain intact and functional, providing an opportunity for therapeutic intervention.
INEXIA
Industry:
Biotechnology Health Care Neuroscience Pharmaceutical
Founded:
2019-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.inexiatherapeutics.com
Total Employee:
1+
Status:
Active
Total Funding:
0
Technology used in webpage:
GoDaddy DNS Google Google Cloud WP Engine
Similar Organizations
Founder
Investors List
Medicxi
Medicxi investment in Seed Round - Inexia
Official Site Inspections
http://www.inexiatherapeutics.com
- Host name: 95.70.73.34.bc.googleusercontent.com
- IP address: 34.73.70.95
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Inexia"
Inexia - Crunchbase Company Profile & Funding
Inexia aims to develop intranasally administered orexin positive modulators for the treatment of neurological diseases.The orexin system is a key regulator of …See details»
Inexia Company Profile - Office Locations, Competitors ... - Craft
Inexia is a therapeutics company that develops intranasally administered orexin positive modulators for the treatment of narcolepsy. Its modulators aim to restore orexin levels in the …See details»
Inexia Company Profile 2024: Valuation, Investors, Acquisition
Inexia General Information Description. Developer of intranasal orexin receptor agonists and positive modulators designed to treat narcolepsy. The company's modulators leverage …See details»
Inexia Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Inexia Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»
Inexia - Centessa Therapeutics (NASDAQ:CNTA) - Medicxi
Inexia aims to develop intranasally administered orexin positive modulators for the the treatment of neurological diseases. The orexin system is a key regulator of behavioural arousal, …See details»
Inexia - Overview, News & Similar companies | ZoomInfo.com
View Inexia (www.inexiatherapeutics.com) location in Greater London, United Kingdom , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
Inexia - Company Profile - Tracxn
Nov 21, 2024 Inexia ranks 587th among 2088 active competitors. 511 of its competitors are funded while 351 have exited. Overall, Inexia and its competitors have raised over $15.8B in …See details»
Inexia - Products, Competitors, Financials, Employees, …
About Inexia. Inexia is a transformational pharmaceutical company engaged in clinical research and the development of medicines. The company's main offerings include the development of …See details»
Company Information - RocketReach
Inexia is developing intranasal orexin receptor agonists and positive modulators for the treatment of narcolepsy, a rare neurological condition that affects the brain's ability to regulate the …See details»
Inexia | VentureRadar
Inexia VentureRadar profile. Find out more about Inexia, Drug Delivery and Formulation.See details»
Inexia - Company Information, Competitors, News & FAQs
Inexia is developing intranasal orexin receptor agonists and positive modulators for the treatment of narcolepsy, a rare neurological condition that affects the brain's ability to regulate the …See details»
Inexia - LinkedIn
Inexia | 127 abonnés sur LinkedIn. Developing intranasally administered orexin agonists and positive modulators for the treatment of neurological disorders | Inexia is developing intranasal …See details»
Inexia Limited | Insights
Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Inexia - Golden
Inexia is a Cambridge, Massachusetts-based company.See details»
Sosei Heptares: Significant Progress by Orexia and Inexia With …
Jan 14, 2020 For more information on Orexia and Inexia, please visit www.orexiatherapeutics.com and www.inexiatherapeutics.com. About Sosei Heptares.See details»
Homepage - Centessa Pharmaceuticals
Patient-Centric Mission. Asset-Centric Approach. We’re pursuing our Orexin Receptor 2 Agonist Program to bring potentially transformative treatment options to patients with sleep-wake, …See details»
Research programme: neurological diseases therapies
Mar 28, 2023 If your organization has a subscription, there are several access options, even while working remotely: Working within your organization’s network Login with …See details»
INGENIA Therapeutics
INGENIA Therapeutics is a research-driven biotechnology company. We are committed to the discovery and development of advanced therapeutics for patients afflicted by inflamed and …See details»
Companies - Medicxi
Inexia aims to develop intranasally administered orexin positive modulators for the the treatment of neurological diseases. The orexin system is a key regulator of behavioural arousal, …See details»
CytoMed Therapeutics signs Business & Research Collaboration …
2 days ago CytoMed Therapeutics signs Business & Research Collaboration Agreement with India’s SunAct Cancer Institute Private Limited to advance use of allogeneic off-the-shelf …See details»